Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine
- PMID:16779778
- DOI: 10.1002/bmc.677
Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine
Abstract
It has been reported that the repeated administration of a sub-anesthetic dose of an N-methyl-D-aspartate receptor antagonist, ketamine, can produce an animal model of schizophrenia. Since no information is available on the alterations of the amino acid levels in ketamine-treated rats, we investigated the amino acid composition in the plasma and cerebrospinal fluid of rats that were repeatedly administered with ketamine for 5 consecutive days (30 mg/kg/day). The plasma and cerebrospinal fluid amino acid compositions in the fifth week after cessation of repeated ketamine administration were determined by highperformance liquid chromatography with fluorescence detection using a pre-column fluorescence reagent, i.e. 4-fluoro-7nitro-2,1,3-benzoxadiazole. Among the amino acids investigated in the present study, the level of plasma glutamic acid increased significantly (p < 0.05), while that of the cerebrospinal fluid glutamic acid decreased significantly in the ketamine-treated rats as compared with these levels in control rats injected with saline (p < 0.05, n = 7). These alterations in the glutamic acid level in the plasma and cerebrospinal fluid resemble those in schizophrenic patients, suggesting that ketamine-treated rats may be a useful model for performing research on the pathophysiology of schizophrenia.
Copyright 2006 John Wiley & Sons, Ltd.
Similar articles
- Behavioral effects associated with chronic ketamine or remacemide exposure in rats.Wright LK, Pearson EC, Hammond TG, Paule MG.Wright LK, et al.Neurotoxicol Teratol. 2007 May-Jun;29(3):348-59. doi: 10.1016/j.ntt.2006.12.004. Epub 2007 Jan 16.Neurotoxicol Teratol. 2007.PMID:17291718
- Determination of amino acid levels in the rat striatum, after administration of ethanol alone and associated with ketamine, a glutamatergic antagonist.Vasconcelos SM, Sales GT, Lima NM, Soares PM, Pereira EC, Fonteles MM, Sousa FC, Viana GS.Vasconcelos SM, et al.Neurosci Lett. 2008 Oct 17;444(1):48-51. doi: 10.1016/j.neulet.2008.08.007. Epub 2008 Aug 7.Neurosci Lett. 2008.PMID:18706482
- Ketamine attenuates sympathetic activity through mechanisms not mediated by N-methyl-D-aspartate receptors in the isolated spinal cord of neonatal rats.Ho CM, Su CK.Ho CM, et al.Anesth Analg. 2006 Mar;102(3):806-10. doi: 10.1213/01.ane.0000195547.35721.ff.Anesth Analg. 2006.PMID:16492832
- The NMDA antagonist model for schizophrenia: promise and pitfalls.Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH.Abi-Saab WM, et al.Pharmacopsychiatry. 1998 Jul;31 Suppl 2:104-9. doi: 10.1055/s-2007-979354.Pharmacopsychiatry. 1998.PMID:9754841Review.
- Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C.Bubeníková-Valesová V, et al.Neurosci Biobehav Rev. 2008 Jul;32(5):1014-23. doi: 10.1016/j.neubiorev.2008.03.012. Epub 2008 Apr 8.Neurosci Biobehav Rev. 2008.PMID:18471877Review.
Cited by
- Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.Glodzik L, King KG, Gonen O, Liu S, De Santi S, de Leon MJ.Glodzik L, et al.Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1005-12. doi: 10.1016/j.pnpbp.2008.01.016. Epub 2008 Feb 7.Prog Neuropsychopharmacol Biol Psychiatry. 2008.PMID:18343551Free PMC article.
- Glutamate Deregulation in Ketamine-Induced Psychosis-A Potential Role of PSD95, NMDA Receptor and PMCA Interaction.Lisek M, Ferenc B, Studzian M, Pulaski L, Guo F, Zylinska L, Boczek T.Lisek M, et al.Front Cell Neurosci. 2017 Jun 28;11:181. doi: 10.3389/fncel.2017.00181. eCollection 2017.Front Cell Neurosci. 2017.PMID:28701926Free PMC article.
- Neurochemical modulators of sleep and anesthetic states.Van Dort CJ, Baghdoyan HA, Lydic R.Van Dort CJ, et al.Int Anesthesiol Clin. 2008 Summer;46(3):75-104. doi: 10.1097/AIA.0b013e318181a8ca.Int Anesthesiol Clin. 2008.PMID:18617819Free PMC article.Review.No abstract available.
- Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T.Fukushima T, et al.PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014.PLoS One. 2014.PMID:25004141Free PMC article.
- Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration.Zhou Z, Zhang G, Li X, Liu X, Wang N, Qiu L, Liu W, Zuo Z, Yang J.Zhou Z, et al.Mol Neurobiol. 2015 Apr;51(2):808-19. doi: 10.1007/s12035-014-8798-2. Epub 2014 Jun 28.Mol Neurobiol. 2015.PMID:24973145
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources